IDH1 and astrocytoma (excluding glioblastoma): Synergistic relationship of missense and indel TP53 mutations were observed within IDH1 mutation contexts, consistent with the known relationship in brain tumors where up to 70% of IDH1-mutant astrocytomas harbor TP53 mutations [47].